Piper Sandler analyst Charles Neivert downgrades Albemarle (NYSE:ALB) from Overweight to Neutral and lowers the price target from $255 to $155.
Piper Sandler analyst Charles Neivert downgrades Albemarle (NYSE:ALB) from Overweight to Neutral and lowers the price target from $255 to $155.